SEC Form 4/A · accession 0000905718-15-000608
CANCER GENETICS, INC · CGIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Steven Hepburn
Officer — VP of Biopharma Marketing
Period of report
May 29, 2015
Accepted (ET)
Jul 14, 2015 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001349929
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1 | May 29, 2015 | A | 3,000 | $0.00 | A | 3,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $11.05 | May 29, 2015 | A | 15,000 | A | Aug 27, 2015 | May 29, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The restricted stock underlying the award vests in three equal installments on May 29, 2016, May 29, 2017 and May 29, 2018, respectively.
- F2The option vests in forty-eight equal monthly installments commencing on August 27, 2015.